ReviewmBio2025
Structural insights into
Review in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Importance of Being Imperfect: Structure and Function of Bacterial Amyloid.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Curli are a widespread component of proteobacterial biofilms. They are functional amyloid fibers that aid in structuring the extracellular matrix that surrounds these multicellular communities. As a functional amyloid, they are the product of a dedicated assembly pathway that needs to navigate the cytotoxicity classically associated with most amyloid depositions. Recent breakthroughs in cryo-EM and protein structure prediction have started to shed light on the unique structural principles of curli fibrils. Here, we revisit the recent literature and focus on the consensus model for these remarkable protein fibrils.IMPORTANCEAmyloid fibrils receive enormous interest as instigators of protein aggregation disorders and associated wasting diseases, as functional components of complex biological matrices, including biofilms, and/or as versatile and self-assembling protein scaffolds for protein material applications. Central to each of these phenomena are the structural properties of the component subunits and how they assemble in the amyloid fibril. A thorough understanding of these architectural principles is essential for the rational interference with amyloids, be it inhibitory in the case of disease-associated amyloids, or as a basis for biotechnological applications of functional amyloids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.